Finland· FI-REL-REL740

Majeptil

A thioproperazine product containing thioproperazine, registered in Finland by Rhone-Poulenc Rorer Oy.

ATC N05AB08

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedMajeptilATCN05AB08REGISTER NO.FI-REL-REL740PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Active substance
Thioproperazine
Manufacturer
Rhone-Poulenc Rorer Oy
Country
Finland (FI)
ATC code
N05AB08
ATC class
Thioproperazine
Defined daily dose
75 mg, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under N05AB08

Thioproperazine, as other registers publish it.

All thioproperazine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cd7cff80-e597-4eb7-ba85-a2ea8e549026
GET /v1/drugs/cd7cff80-e597-4eb7-ba85-a2ea8e549026?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "75",
  "form": "tabletti",
  "route": null,
  "ddd_unit": "mg",
  "strength": "25 mg",
  "atc_label": "tioproperatsiini",
  "ma_number": "5920",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL740",
  "authorised_at": "1969-10-22"
}

See everything about thioproperazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.